Please assess the completion status of the following clinical trial:

Trial Title: Assessment of the Skin-concentration of Vildagliptin 50 mg Every 12 Hours for 10 Days in Healthy Subjects and Patients With Type 2 Diabetes

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy volunteers and patients with type 2 diabetes~* Non-smoking, Caucasian and African American, male and female (postmenopausal, surgically sterile or using double-barrier method of contraception) subjects between 30 and 65 years of age (inclusive)~* Type 2 diabetics on metformin and/or sufonylurea~Exclusion Criteria:~* History of type 1 diabetes or insulin use~* History of coagulation abnormalities~* History of abnormal heart conditions~* Pregnancy or breastfeeding~Other protocol-defined inclusion/exclusion criteria may apply

- Gender: ALL
- Minimum Age: 30 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: EXPERIMENTAL): Healthy volunteers
- 2 (Type: EXPERIMENTAL): Type II diabetics

Based on this trial design, predict the completion outcome and termination type (if applicable).